Clin Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomas-Dobersen, D.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Thomas-Dobersen, D.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Clinical Diabetes 21:190-192, 2003
© American Diabetes Association ®, Inc., 2003


Case Study

Case Study: A 64-Year-Old Man With a 9-Year History of Type 2 Diabetes in Whom Insulin Therapy Led to Improved Control But No Weight Gain After 6 Months

Deborah Thomas-Dobersen, RD, MS, CDE

The first 20% of the full text of this article appears below.


    Presentation
 
L.T. is a 64-year-old white man with a 9-year history of type 2 diabetes. He suffered an inferior wall myocardial infarct 2 years ago. He also has a 7-year history of hypertriglyceridemia and hypercholesterolemia, as well as gout and abdominal obesity. He has no history of cigarette smoking.

At his initial visit to the endocrinology clinic, his weight was 242 lb., and he was 70 inches tall. Thus, his BMI was 35 kg/m2. His blood pressure was 130/78 mmHg, and his hemoglobin A1c (A1C) result was 9.0% (normal: 4.3–6.1%) on 2,000 mg/day of metformin and 10 mg/day of glyburide. A lipid panel revealed fasting serum triglycerides of 288 mg/dl, total cholesterol of 160 mg/dl, HDL cholesterol of 36 mg/dl, and LDL cholesterol of 66 mg/dl. His fasting blood glucose level was 331 mg/dl. In addition to metformin and glyburide, medications included simvastatin, 10 mg/day; niacin,750 mg twice daily; allopurinal, 300 mg/day; and aspirin, 325 mg/day.

L.T.’s primary care provider had been reluctant to start him on insulin, even though he was taking close-to-maximal doses of oral hypoglycemic agents without achieving acceptable diabetes control. The provider worried that, once L.T. started on insulin, he would regain the 20 lb. he had lost since his myocardial infarct and that the negative impact of this weight gain would outweigh the positive impact of enhanced diabetes control on his overall health. Taking these concerns into account, the endocrinologist started L.T. on 10 units/day of glargine at bedtime, to be taken in addition to his regimen of metformin and glyburide.

L.T. and his wife then scheduled an appointment for medical nutrition therapy (MNT) with a registered dietitian who was a certified diabetes educator. L.T.’s 3-day food record showed excessive calorie intake with > 90–120 g of carbohydrate per meal. The dietitian taught the . . . [Full Text of this Article]


    Questions
 

    Commentary
 

    Clinical Pearls
 

Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2003 by the American Diabetes Association.